Total planned funding: $65,718,817
Allocations
Countries/Regions
| Central Asia Region | $65,718,817 |
Organizational Types
| Own Agency | $20,637,149 |
| Unknown | $15,341,387 |
| University | $9,810,792 |
| NGO | $7,620,994 |
| Host Country Government Agency | $6,456,266 |
| Private Contractor | $4,282,129 |
| Multi-lateral Agency | $1,345,000 |
| Implementing Agency | $167,000 |
| Other USG Agency | $58,100 |
Program Areas
| Prevention | $19,615,810 |
| Management and Operations | $14,392,970 |
| Governance and Systems | $14,244,304 |
| Care | $9,031,611 |
| Testing | $4,926,021 |
| Treatment | $3,508,101 |
Budget Codes
| HVMS: Management and Operations | $14,392,970 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $13,999,429 |
| HBHC: Care: Adult Care and Support | $7,647,209 |
| HLAB: Laboratory Infrastructure | $5,252,781 |
| HVCT: Testing: HIV Testing and Counseling | $4,926,021 |
| HVSI: Strategic Information | $4,536,283 |
| OHSS: Health Systems Strengthening | $4,455,240 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $3,976,854 |
| HTXS: Treatment: Adult Treatment | $3,482,081 |
| HVTB: Care: TB/HIV | $1,384,402 |
| HMBL: Biomedical Prevention: Blood Safety | $1,215,461 |
| HMIN: Biomedical Prevention: Injection Safety | $424,066 |
| HTXD: Treatment: ARV Drugs | $26,020 |
Top Partner Programs
USG Aggregated Agencies:
$15,274,786
Countries/Regions
Central Asia Region
| 2011 | $5,099,999 |
| 2012 | $1,121,824 |
| 2015 | $4,926,674 |
| 2016 | $4,126,289 |
Not Available:
$15,241,387
Countries/Regions
Columbia University:
$9,810,792
Countries/Regions
Ministry of Health - Kyrgyz Republic:
$3,720,646
Countries/Regions
Central Asia Region
| 2012 | $90,250 |
| 2014 | $910,000 |
| 2015 | $1,100,000 |
| 2016 | $1,620,396 |
Abt Associates:
$3,632,129
Countries/Regions
Central Asia Region
| 2011 | $2,232,129 |
| 2012 | $0 |
| 2014 | $1,400,000 |
| 2015 | $0 |